Prosecution Insights
Last updated: April 19, 2026

Chengdu Biobel Biotechnology Co. Ltd.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
0
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18562555 RECEPTOR-INTERACTING PROTEIN INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF VALENROD, YEVGENY 1628 Non-Final OA Nov 20, 2023
18547763 NITROTHIAZOLE DERIVATIVE AND APPLICATION THEREOF DAHLIN, HEATHER RAQUEL 1629 Non-Final OA Aug 24, 2023

Managing Chengdu Biobel Biotechnology Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month